Penumbra Inc stock is traded at $321.72, with a volume of 320,187. It is up +0.08% in the last 24 hours and up +0.24% over the past month. Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.
Previous Close:
$321.46
Open:
$321.00
24h Volume:
320,187
Relative Volume:
0.82
Market Cap:
$12.68B
Revenue:
$1.45B
Net Income/Loss:
$171.05M
P/E Ratio:
74.03
EPS:
$4.35
Net Cash Flow:
$212.73M
1W Performance:
+0.19%
1M Performance:
+0.24%
6M Performance:
-0.33%
1Y Performance:
+14.78%
1-Day Range:
$320.28$322.24
1-Week Range:
$319.00$322.90
52-Week Range:
$271.32$362.41
Penumbra Inc Stock (PEN) Company Profile
Name
Penumbra IncSector
HealthcareIndustry
Medical DevicesPhone
(510) 995-2486Address
ONE PENUMBRA PLACE, ALAMEDA, CA, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS